Breast: Page 468

Dr. Daniel B. Kopans on the AHRQ report, "Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities"
Dr. Daniel B. Kopans, professor of radiology at Boston-based Harvard Medical School and director of breast imaging at Massachusetts General Hospital, weighs in on the Agency for Healthcare Research and Quality (AHRQ) report, "Effectiveness of Noninvasive Diagnostic Tests for Breast Abnormalities."
February 26, 2006
Kodak appoints LeGrand as VP
By AuntMinnie.com staff writers
Eastman Kodak Health Group has named Anne LeGrand as vice president and general manager of output systems and mammography solutions, according to the Rochester, NY-based firm.
February 22, 2006
SenoRx adds new probe
By AuntMinnie.com staff writers
Breast cancer interventional device firm SenoRx has released a new 7-gauge size probe for its EnCor multimodality breast biopsy device.
February 22, 2006
Fuji gets CR mammo approval in Canada
By AuntMinnie.com staff writers
Fujifilm Medical Systems has obtained a Class III license from Health Canada for the distribution of its FCR Profect CS computed radiography system for mammography use in Canada.
February 20, 2006
Sectra notches MicroDose mammo sales
By AuntMinnie.com staff writers
Healthcare IT and women's imaging vendor Sectra of Linköping, Sweden, has sold  MicroDose Mammography digital mammography systems to clinics in Switzerland, Austria, and New Zealand, representing the first such sales into these markets for the developer.
February 20, 2006
Medipattern posts first revenue
By AuntMinnie.com staff writers
Computer-aided detection (CAD) firm Medipattern reported fiscal second-quarter revenue from operations of $314,000, the first noninterest revenue booked by the firm.
February 15, 2006
APBI variables affect late tissue toxicity, cosmetic outcome
By Shalmali Pal
Accelerated partial-breast irradiation (APBI) combines high radiation doses, and a shorter treatment period, with one of four delivery methods including interstitial brachytherapy or intraoperative radiation therapy. But little is known about the associated delayed tissue toxicity. A new study details how APBI-related variables can influence tissue toxicity and cosmetic outcome.
February 12, 2006
New report slams breast imaging as flawed compared to biopsy
By AuntMinnie.com staff writers
All alternative breast imaging modalities are insufficient for detecting cancer and are not a viable replacement for biopsy, according to a report released today by the Agency for Healthcare Research and Quality (AHRQ).
February 8, 2006
MR mammography: Screening tool or diagnostic adjunct?
Over the years, MR scanners have evolved to become faster and stronger. MRI has a valuable role in the diagnosis of breast cancer; however, it is not for patients of low or normal risk and should be reserved for patients at high risk. It is also important for problem-solving in patients with complex mammograms, for preoperative planning, and for monitoring therapy in patients with breast cancer.
February 8, 2006
2006 02 08 16 48 56 706
Signal-intensity curve characteristics
February 8, 2006
Scan protocol
February 8, 2006
BI-RADS classifications
February 8, 2006
Previous Page
Page 468 of 579
Next Page